BOOK REVIEWS 77 obtain yes/no answers at alpha = 0.05, whereas this formulation is almost useless to the policy maker, who is more interested in the amount of improvement that can be expected in different segments ofsociety and the translation of that into demographic and economic terms. Third, the book is revealing to those who imagine that even the best-designed studies really answer the original questions definitively. A controversial suggestion made in one of the discussions is that the investigators in a clinical trial should be prohibited from drawing the policy-related conclusions from their research! Obviously, there are arguments against, as well as for, this position.
an intellectually stimulating textbook for medical students, practicing clinicians, clinical researchers, and epidemiologists. The text is an excellent resource for those who evaluate clinical research, and it also serves as a valuable introduction to the epidemiologic methods and techniques used for conducting clinical investigations. Epidemiologists will find the clinical perspective of epidemiologic issues refreshing, yet the book is not a substitute for a comprehensive epidemiology text.
Dr. Feinstein separates the book into seven parts that provide an overview of clinical research. The subjects discussed include: an overview of research architecture, an outline of statistical strategies, additional principles of cause-effect research, structure science and statistics in cross-sectional research, non-cohort structures in cause-effect research, evaluation of processes, and additional topics. These parts are reasonably distinct intellectual units, but one of the strengths of the text is the continuity carried from section to section. The author is extremely successful in demonstrating the clinical relevance of the research strategies he presents, and it is this clinical perspective that facilitates smooth and understandable transitions.
Perhaps the greatest strength of the book is that the author is not constrained by traditional approaches to epidemiology in his intellectual quest for rigorous science. With an almost brazen disregard for his epidemiologic heritage, Dr Clinical Epidemiology is an interesting presentation of a field that is generally not described in clinically applicable terms; however, the author's discussion of several epidemiologic methods and principles is incomplete. For example, limitations in the use of the kappa coefficient as a method of quantifying inter-observer agreement are not adequately addressed. In addition, confounding receives too little attention considering its importance in conducting and evaluating research. These shortcomings are important but do not diminish the relevance of understanding epidemiologic techniques in a clinical setting. Clinical investigators will find the text to be a valuable supplemental resource for conducting research, while other readers will discover it to be an insightful tool for evaluating clinical research.
The author achieves a rare balance with In the first section, "Tumor Antigen Characterization," an opening chapter by editor Reif detailing requirements for success in immunotherapy is followed by a discussion on the origin and nature of tumor antigens. Specific tumor antigens in human melanoma, lymphoma, Simian virus 40 transformed cells, and leukemia are discussed in the eight papers that follow, and the means of their characterization is described.
"Immune Responses to Tumor Antigens" is the topic of the second section, with the emphasis on effector mechanisms, including NK, macrophage, humoral, and T-cell responses to challenge by tumor antigens. The regulation of these responses is the subject of the third section, where cellular interaction and the role of lymphokines in tumor rejection is reviewed.
The fascinating field of biological response modifiers (BRMs) is the subject of the fourth section. Both reviews of current developments and original research are presented, as thymosins, extracted tumor-specific transplantation antigens, and interleukin 2 are discussed as possible inducers of the immune response against neoplasia.
